Trial·ClinicalTrials.gov
Phase II protocol amendment — KRAS G12C, NSCLC, expanded cohort
Healthcare & biotech intelligence
AI-native intelligence across trials, regulators, drugs and competitors — in one subscription.
Quorvex ingests feeds from FDA, EMA, MHRA, ClinicalTrials.gov, peer-reviewed publications, and public corporate disclosures. Agentic AI extracts, summarises, and routes signals by therapeutic area, indication, sponsor, or modality — so your team sees what matters before it hits press release.
Want to try it yourself? Enter your email and you're in for 48 hours.
Early access
Be first in line.
We'll only email you at launch — no spam, unsubscribe anytime.
- 4
- streams unified
- 6+
- authoritative sources
- 1
- transparent subscription
Live signal feed
Real-time alerts, routed by your subscriptions
● live
12 min ago
Regulatory·FDA
Advisory committee vote scheduled — gene therapy, Class III
Approval·Company filing
Label expansion granted — anti-CD20, third-line indication
Regulatory·EMA
CHMP positive opinion — GLP-1 oral formulation
Competitor·PubMed
Analyst-curated brief: competitive landscape — bispecifics, hematology
Now piloting
Real-time FDA monitoring — live with select partners.
We're piloting sub-minute FDA action capture with a small group of regulatory and BD teams. If recalls, advisories and approvals are table stakes for your team, you should be in the pilot — we're onboarding a few more partners before general availability.
Sub-minute FDA action capture
Recall notices, advisory committee votes, drug safety communications and complete response letters — pushed to your dashboard before the press release.
Recall & advisory alerts in your digest
Sponsor- and indication-filtered. Quiet hours respected. No paging your on-call at 3am for a competitor filing.
Sponsor & indication routing
Subscribe to the entities you cover; FDA monitoring collapses into the same unified feed you already use for trials and approvals.
Pilot slots: 5 remaining this quarter.
FDA monitor — live
Pilot instrumented feed, last 60 seconds
live
events / 60s14 captured
FDA·Recall
Class II recall posted — infusion pump firmware, manufacturer XYZ
FDA·Advisory
Drug safety communication — label update, oral anticoagulant cohort
FDA·Approval
New molecular entity approved — orphan designation, rare neuromuscular
Illustrative snapshot for the public site. Pilot-partner dashboards render a live stream from monitored FDA sources — recall notices, advisory committee notices, drug safety communications, and approval letters.
The four streams
Four feeds your team pays for separately. One unified subscription.
Today, most biotech & pharma teams license Contify, AlphaSense, and Citeline as separate contracts. Quorvex consolidates them behind a single API and a single dashboard — with the same coverage, transparent mid-market pricing.
Clinical trials
Protocol amendments, enrollment shifts, endpoint changes, readouts — before they hit press release.
Sources
- ClinicalTrials.gov
- EU CTR
- WHO ICTRP
- Sponsor portals
✓approved
Regulators
FDA, EMA, MHRA — advisory committee votes, type-A meetings, priority review designations, complete response letters.
Sources
- FDA Drugs
- FDA Devices
- EMA EPAR
- MHRA
Drugs & approvals
New molecular entity approvals, label expansions, generic entries, REMS updates — every decision captured.
Sources
- Orange Book
- EPAR
- SPL
- Drug@FDA
Competitors
Public corporate disclosures, peer-reviewed publications, earnings call flow — routed by sponsor, indication, modality.
Sources
- SEC filings
- PubMed
- Earnings calls
- Investor decks
Filter by:
Competitive intelligence
Regulatory affairs
Business development
Clinical operations
Investor relations
Pipeline strategy
How it works
From source filing to your inbox — in minutes.
Agentic AI does the heavy lifting. You subscribe to what matters; we route what matches.
- 01
Ingest
Continuous, monitored pulls from FDA, EMA, MHRA, ClinicalTrials.gov, peer-reviewed journals, and corporate disclosures.
- 02
Extract
Agentic AI parses dense filings into structured signal records — sponsor, indication, modality, phase, geography.
- 03
Route
Subscribe by therapeutic area, indication, sponsor, or modality. Signal or quiet hours — your call.
- 04
Deliver
Real-time alerts in the dashboard, AI digests in your inbox, weekly analyst briefs, and CRO-ready exports for your stack.
Pricing
Three plans. Four streams. No per-seat math.
Mid-market transparent pricing — built for teams that pay real money for enterprise licensing elsewhere. No per-seat math, no surprise overage.
Compare plans
What's in each plan.
Every capability the way we measure it — line by line. No asterisks.
| Capability | Starter | Team | Enterprise |
|---|---|---|---|
| Seats | 1 | Up to 5 | Unlimited |
| Alert channels | FDA + ClinicalTrials.gov | + EMA digest | + EMA live + MHRA |
| API rate limits | — | coming soon | Custom |
| Export formats | CSV | CSV + JSON | CSV + JSON + Parquet |
| Support SLA | Email — best-effort | Email — 1 business day | 24/7 + named CSM |
Frequently asked
Questions buyers ask before signing.
One subscription that replaces four.
Replace Contify + AlphaSense + Citeline with a single, AI-native feed. Talk to us — we will share a one-week curated signal preview from the live platform on your therapeutic area before any commitment.